Published in J Immunol on September 01, 1968
Immunity to retroviral infection: the Friend virus model. Proc Natl Acad Sci U S A (1997) 2.28
Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc Natl Acad Sci U S A (2001) 2.04
Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proc Natl Acad Sci U S A (1995) 1.33
Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. J Virol (1995) 1.18
Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression. J Exp Med (1986) 1.15
Essential roles for CD8+ T cells and gamma interferon in protection of mice against retrovirus-induced immunosuppression. J Virol (2002) 1.05
Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev (2012) 0.97
Suppression of established Friend virus leukemia by statolon. I. Demonstration of a latent infection in clinically normal mice. J Virol (1969) 0.92
Immunodepression by Rowson-Parr virus in mice. II. Effect of Rowson-Parr virus infection on the antibody response to sheep red cells in vivo and in vitro. Infect Immun (1973) 0.91
Antibody-forming cells and serum hemolysin responses of pastel and sapphire mink inoculated with Aleutian disease virus. Infect Immun (1973) 0.91
Divergence between immunosuppression and immunocompetence during virus-induced leukemogenesis. Proc Natl Acad Sci U S A (1971) 0.89
Nucleases in immunity. I. The effect of immunization on RNase and DNase activity in lymphoid tissues. Clin Exp Immunol (1970) 0.84
The cellular basis of immunosuppression caused by the radiation leukaemia virus. Immunology (1974) 0.82
Immunosuppression by murine sarcoma virus (Moloney). Infect Immun (1970) 0.77
Effect of human adenoviruses on the response of chickens to sheep erythrocytes. Infect Immun (1973) 0.75
Nucleases in immunity. II. Ineffectiveness of exogenous RNase on the antibody plaque response of immunized mice. Clin Exp Immunol (1970) 0.75
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol (1992) 4.85
A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet (1990) 2.89
Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol (1986) 2.37
Growth of Legionella pneumophila in thioglycolate-elicited peritoneal macrophages from A/J mice. Infect Immun (1988) 2.37
The importance of measuring cotinine levels to identify smokers in clinical trials. Clin Pharmacol Ther (1994) 2.11
A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer. Oncogene (2000) 2.07
Direct localization and visualization of hyaluronate lyase activity by agar gel electrophoresis. Proc Soc Exp Biol Med (1967) 2.00
There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys (1999) 1.96
Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995. Arch Pediatr Adolesc Med (2000) 1.95
Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin. Proc Soc Exp Biol Med (1974) 1.76
Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol (2001) 1.74
Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukoc Biol (1988) 1.73
Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol (1988) 1.70
Differences in HLA class II alleles of isolated South American Indian populations from Brazil and Argentina. Hum Immunol (1993) 1.69
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. J Immunol (1986) 1.62
Effects of RES "blockade" on antibody-formation. I. Suppressed cellular and humoral haemolysin responses in mice injected with carbon particles. Immunology (1969) 1.61
Radiometric detection of bacteremia: requirement for terminal subcultures. J Clin Microbiol (1977) 1.61
Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infect Immun (1994) 1.54
Cryptococcal capsular polysaccharide-induced modulation of murine immune responses. Infect Immun (1982) 1.47
Fatigue in Parkinson's disease. Neurology (1993) 1.46
Legionella pneumophila-induced blastogenesis of murine lymphoid cells in vitro. Infect Immun (1984) 1.39
Building collaborative relationships with families of the mentally ill. Hosp Community Psychiatry (1988) 1.38
Variability of X-ray emission from M87. Nature (1971) 1.38
Vibrio vulnificus resists phagocytosis in the absence of serum opsonins. Infect Immun (1985) 1.35
Temperature control of initiation of protein synthesis in Escherichia coli. J Mol Biol (1971) 1.32
Immunosuppressive effects of Friend and Rauscher leukemia disease viruses on cellular and humoral antibody formation. J Natl Cancer Inst (1968) 1.31
Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J Immunol (1989) 1.30
Outcomes of extremely low birth weight infants. Pediatrics (1996) 1.28
Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. J Immunol (2000) 1.28
Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun (1995) 1.28
The cannabinoid system and cytokine network. Proc Soc Exp Biol Med (2000) 1.27
Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect Immun (1994) 1.27
Viral hepatitis, type A. Identification by specific complement fixation and immune adherence tests. N Engl J Med (1975) 1.25
Population study of triazolam pharmacokinetics. Br J Clin Pharmacol (1986) 1.24
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24
Differential growth of Legionella pneumophila in guinea pig versus mouse macrophage cultures. Infect Immun (1987) 1.21
Marijuana, immunity and infection. J Neuroimmunol (1998) 1.21
Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun (1994) 1.21
Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species. Infect Immun (1983) 1.20
Variation in antigenic determinants of p53 transformation-related protein obtained from various species. J Immunol (1983) 1.19
Dorsal column stimulation for control of pain. Preliminary report on 30 patients. J Neurosurg (1972) 1.18
Cannabinoid receptors and immunity. Immunol Today (1998) 1.17
Comparison of a radiometric procedure with conventional methods for identification of Neisseria. J Clin Microbiol (1978) 1.17
Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity. J Leukoc Biol (1989) 1.17
MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol (1994) 1.17
Electromicturition in paraplegia. Implantation of a spinal neuroprosthesis. Arch Surg (1972) 1.15
Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts. J Immunol (1975) 1.14
Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2. J Immunol (1987) 1.14
Modulation of in vivo antibody responses by cholera toxin. J Immunol (1975) 1.14
Immunologic tolerance to Escherichia coli somatic antigen assessed by bacteriolytic and hemolytic plaque assays. J Immunol (1970) 1.13
Interferon-gamma induced resistance to Legionella pneumophila in susceptible A/J mouse macrophages. J Leukoc Biol (1991) 1.13
Role of gamma interferon in induction of natural killer activity by Legionella pneumophila in vitro and in an experimental murine infection model. Infect Immun (1988) 1.12
The effect of RES blockade on cellular antibody formation to sheep erythrocytes. Proc Soc Exp Biol Med (1968) 1.12
Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes. Proc Soc Exp Biol Med (1977) 1.12
Ribosomal subunits produced by cold sensitive initiation of protein synthesis. Nature (1969) 1.11
Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study. J Pediatr Hematol Oncol (2001) 1.10
Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes (1994) 1.10
Cellular basis for the immunosuppressive properties of a leukaemogenic virus. Nature (1968) 1.09
The pharmacokinetics of doxylamine: use of automated gas chromatography with nitrogen-phosphorus detection. J Clin Pharmacol (1985) 1.08
Cosmic X-ray Sources. Science (1965) 1.08
Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA. Infect Immun (1994) 1.08
Lymphoid cell blastogenesis as an in vitro indicator of cellular immunity to Legionella pneumophila antigens. J Clin Microbiol (1984) 1.08
A rapid [3H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J Immunol Methods (1986) 1.08
Antibody-mediated bacteriolysis: enhanced killing of cyclacillin-treated bacteria. Proc Soc Exp Biol Med (1976) 1.07
Transient lateral patellar dislocation: diagnosis with MR imaging. AJR Am J Roentgenol (1993) 1.07
Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children. Pediatrics (1998) 1.06
Migration of mouse lymphocytes in vitro from capillary tube cultures. Proc Soc Exp Biol Med (1969) 1.06
Stimulation of an enhanced in vitro immune response by a synthetic adjuvant, muramyl dipeptide. J Immunol (1978) 1.06
Development of antibody-forming cells in neonatal mice: stimulation and inhibition by calf thymus fractions. J Immunol (1970) 1.06
Immunosuppression and the role of suppressive factors in cancer. Adv Cancer Res (1977) 1.06
Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning (1990) 1.05
Human submandibular saliva aggregates HIV. AIDS Res Hum Retroviruses (1993) 1.05
A simplified procedure for in vitro immunization of dispersed spleen cell cultures. J Immunol Methods (1976) 1.05
Effects of RES "blockade" on antibody formation. II. Cytokinetics of the secondary haemolysin response and suppressed immunological "memory" in mice treated with carbon particles. Immunology (1969) 1.05
Macrophage permissiveness for Legionella pneumophila growth modulated by iron. Infect Immun (1994) 1.04
Alveolar macrophage cell line MH-S is valuable as an in vitro model for Legionella pneumophila infection. Am J Respir Cell Mol Biol (2001) 1.03
Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J Pharmacol Exp Ther (1998) 1.03
Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus. J Immunol (1974) 1.03
Rapid detection of bacterial growth in blood samples by a continuous-monitoring electrical impedance apparatus. J Clin Microbiol (1977) 1.03
High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. J Clin Oncol (1996) 1.03
Intraspinal rheumatoid nodule causing nerve root compression. Case report. J Neurosurg (1970) 1.03
Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation. Eur J Pharmacol (2001) 1.02
Suppressive effect of leukemia virus-infected lymphoid cells on in vitro immunization of normal splenocytes. J Natl Cancer Inst (1974) 1.02
Legionella pneumophila growth in macrophages from susceptible mice is genetically controlled. Proc Soc Exp Biol Med (1991) 1.01
Staphylococcal hyaluronate lyase: purification and characterization studies. J Bacteriol (1968) 1.01
Vibriolytic antibody-forming cells: a new application of the Pfeiffer phenomenon. Science (1970) 1.01
Quantitative reverse transcription-PCR analysis of Legionella pneumophila-induced cytokine mRNA in different macrophage populations by high-performance liquid chromatography. Clin Diagn Lab Immunol (1995) 1.00
Leukemia virus-induced immunosuppression. IX. Depression of delayed hypersensitivity and MIF production after infection of mice with Friend leukemia virus. J Immunol (1973) 1.00
Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients. Clin Diagn Lab Immunol (1995) 1.00
Induction of tumor necrosis factor by Legionella pneumophila. Infect Immun (1987) 1.00